berbamine has been researched along with Multiple Myeloma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Wu, SG; Zhang, GL | 1 |
Li, M; Liang, Y; Wang, P; Wu, B; Wu, Z; Xu, R; Xu, Y; Yang, L | 1 |
He, X; Li, X; Liang, Y; Qiu, X; Xu, R; Zhang, L; Zhang, X; Zhao, X | 1 |
Liang, Y; Wei, YL; Xu, RZ; Zhao, XY | 1 |
Liang, Y; Xu, RZ; Zhang, L; Zhao, XY | 1 |
Bastide, JM; Benoit-Vical, F; Fouraste, I; Mallié, M; Moulis, C; Stanislas, E; Valentin, A | 1 |
6 other study(ies) available for berbamine and Multiple Myeloma
Article | Year |
---|---|
Synthesis and antitumor activity
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship | 2021 |
CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Benzylisoquinolines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Female; Gene Knockdown Techniques; Humans; Kaplan-Meier Estimate; Male; MAP Kinase Signaling System; Mice; Middle Aged; Multiple Myeloma; Neoplasm Staging; Phosphorylation; STAT3 Transcription Factor; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways.
Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Biological Products; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; Multiple Myeloma; NF-kappa B; Phosphorylation; Protein Biosynthesis; Signal Transduction | 2016 |
[Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway].
Topics: Apoptosis; Benzylisoquinolines; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; JNK Mitogen-Activated Protein Kinases; Multiple Myeloma; Nuclear Proteins; Signal Transduction | 2009 |
Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzylisoquinolines; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dexamethasone; DNA-Binding Proteins; Doxorubicin; G1 Phase; Humans; I-kappa B Kinase; Intracellular Signaling Peptides and Proteins; Multiple Myeloma; NF-kappa B; Nuclear Proteins; Oxides; Plasma Cells; Signal Transduction; Tumor Necrosis Factor alpha-Induced Protein 3 | 2009 |
In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides.
Topics: Alkaloids; Antimalarials; Benzylisoquinolines; Chloroquine; Erythrocytes; Fibroblasts; Humans; Isoquinolines; Malaria, Falciparum; Multiple Myeloma; Plant Extracts; Plant Roots; Plants, Medicinal; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 1997 |